Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/RYBREVANT SC

Authorized

STANDARD

RYBREVANT SC

Janssen Inc🇨🇦 Health Canada

Approval Date: Jun 23, 2026
Approval ID: ed58513dc8e272a5
Company: Janssen Inc
Type: Standard

Approval Details

Approval Id: ed58513dc8e272a5
Drug Approval Canada Name: RYBREVANT SC
Product Name: RYBREVANT SC
Status: Approved
Status Date: 2026-06-18
Din: 02569167
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: SCHEDULE D , PRESCRIPTION
Atc Original: L01FX18 AMIVANTAMAB
Aig Number: 0163501002
Company Name: Janssen Inc
Company Address: 19 Green Belt Drive Toronto Ontario Canada M3C 1L9
Company Detail Path: /organization/janssen-inc

Company Information

Pharmaceutical Company Name: Janssen Inc
Country Name: Canada
Province Name: Ontario
City Name: north york,ontario,country_ca
Address: 19 Green Belt Dr

Active Ingredients

AMIVANTAMAB

2400 MG / 15 ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jun 23, 2026

Approval ID

ed58513dc8e272a5

Type

Standard

Back to Health Canada Approvals

RYBREVANT SC - Health Canada Drug Approval Details